Duration-dependent changes in calcium responsiveness in the alloxan-diabetic rat intestine

Journal of Diabetes and its Complications

Volumn 10, Issue 5, 1996, Pages 288-293

  Öztürk, Yusuf ^a   Altan, V Melih ^b   Yildizoǧlu Ari, Nuray ^b  

^a ANADOLU UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; POTASSIUM;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; DUODENUM; GASTROINTESTINAL SYMPTOM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030578922     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/1056-8727(95)00067-4     Document Type: Article

References (41)

1. 1. Ogbonmaya KI, Arem R: Diabetic diarrhea: Pathophysiology, diagnosis and management. Arch Intern Med 150: 262-267, 1990.
2. 2. Sheridan EP, Bailey CC: Diabetic nocturnal diarrhea. JAMA 130:632-634, 1946.
3. 3. Hosking DJ, Bennett T, Hampton JR: Diabetic autonomic neuropathy. Diabetes 27:1043-1055, 1978.
4. 4. Katz LA, Spiro H: Gastrointestinal manifestations of diabetes. N Engl J Med 275:1350-1361, 1966.
5. 5. McNally EF, Reinhard A, Schwartz P: Small bowel motility in diabetics. Am J Dig Dis 14:163-169, 1969.
6. 6. Battle WM, Snape WJ Jr, Alvi A, Cohen S, Braunstein S: Colonic dysfunction in diabetes mellitus. Gastroenterology 79:1217-1221, 1980.
7. 7. Clark BF, Ewing DJ, Campbell IW: Diabetic autonomic neuropathy. Diabetologia 17:195-212, 1979.
8. 8. Hosking DJ, Moody F, Stewart IM, Atkinson M: Vagal impairment of gastric secretion in diabetic autonomic neuropathy. BMJ 270:588-590, 1975.
9. 9. Nelson JS, Lacy PE, Hirshberg GE: Megacolon and autonomic neuropathy in diabetic rats [Abstract]. J Neuropath Exp Neurol 35:335, 1976.
10. 10. Scott LD, Ellis TM: Small intestinal transit and myoelectric activity in diabetic rats, in Christensen J (ed), Gastrointestinal Motility. New York, Raven, pp. 395-399, 1980.
11. 11. Schmidt RE, Nelson JS, Johnson EM: Experimental diabetic autonomic neuropathy. Am J Pathol 103:210-225, 1981.
12. 12. Lincoln J, Bokor JT, Crowe R, Griffith SG, Haven AJ, Burnstock G: Myenteric plexus in streptozotocin-treated rats: neurochemical and histochemical evidence for diabetic neuropathy in the gut. Gastroenterology 86:654-661, 1984.
13. 13. Öztürk Y, Özçelikay AT, Yildizoǧlu-Ari N, Altan VM, Altinkurt O: Effect of diabetes on histamine-induced gastric acid secretion in the rat [Abstract]. Eur J Pharmacol 183:2091, 1990.
14. 14. Özçelikay AT, Altan VM, Yildizoǧlu-Ari N, Altinkurt O, Onur F, Öztürk Y: Basal and histamine-induced gastric acid secretion in alloxan diabetic rats. Gen Pharmacol 24:121-126, 1993.
15. 15. Altan VM, Yildizoǧlu-Ari N, Öztürk Y: Decreased gastrointestinal responses to certain agonists in streptozotocin-and alloxan-diabetic rats in vitro. Pharmacology 34: 143-148, 1987.
16. 16. Öztürk Y, Yildizoǧlu-Ari N, Özüarin A, Özçelikay AT, Altan VM: Decresed β-adrenergic responses of rat small intestine due to non-insulin-dependent diabetes. Diabetes Res Clin Pract 9:123-127, 1990.
17. 17. Öztürk Y, Altan, VM, Özçelikay AT, Yildizoǧlu-Ari N: Beneficial effect of insulin on these decreased gastrointestinal β-adrenergic responses in streptozotocin-diabetic rats: A contributing role of protein biosynthesis. Arch Int Pharmacodyn Ther 317:81-92, 1992.
18. 18. Öztürk Y, Altan VM, Yildizoǧlu-Ari N: β-Adrenergic responsiveness of the gastrointestinal tract in diabetic rats. Pharmacol Toxicol 71:250-253, 1992.
19. 19. Öztürk Y, Yildizoǧlu-Ari N, Altan VM, Özçelikay AT: Effect of insulin on the decreased β-Adrenergic responses of duodenum and atrium isolated from streptozotocin diabetic rats. Gen Pharmacol 24:217-223, 1993.
20. 20. Yildizoǧlu-Ari N, Altinkurt O, Öztürk Y, Altan VM, Pekiner C, Karasu Ç: Decreased gastrointestinal responses to salbutamol and serotonin in streptozotocin-induced diabetes: Improving effect of insulin in vivo and in vitro. Gen Pharmacol 19:665-668, 1988.
21. 21 Altan VM, Öztürk Y, Yildizoǧlu-Ari N, Nebigil C, Lafçi D, Özçelikay AT: Insulin action on different smooth muscle preparations. Gen Pharmacol 20:529-535, 1989.
22. 22. Öztürk Y, Yildizoǧlu-Ari N, Altan N, Altan VM: Effect of lithium on gastrointestinal complications in alloxan-diabetic rats. Gen Pharmacol 23:769-773, 1992.
23. 23. Öztürk Y, Yildizoǧlu-Ari N, Pekiner C, Özçelikay AT, Altan VM: Vanadate treatment reverses gastrointestinal complications in the streptozotocin diabetic rats. Gen Pharmacol 25:1109-1114, 1994.
24. 24. Öztürk Y, Yildizoǧlu-Ari N, Özüari A, Altan VM: The effects of glyburide and insulin on the decreased β-adrenergic responsiveness of the gastrointestinal tract in rats with non-insulin-dependent diabetes. Gen Pharmacol 25: 1511-1517, 1994.
25. 25. Foil de Cuneo M, Ruiz RD, Lacuara JL, Santillian De Torres R: Contractility and pharmacological reactivity of isolated vascular smooth muscle from diabetic rats. Pharmacology 36:228-237, 1988.
26. 26. Fulton DJR, Hodgson WC, Sikorski BW, King RG: Attenuated responses to endothelin-1, KCl and CaCl2, but not noradrenaline, of aortae from rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol 104:928-932, 1991.
27. 27. Head RJ, Longhurst PA, Panek RL, Stitzel RE: A contracting effect of diabetic state upon contractile responses of aortic preparations from the rat and the rabbit. Br J Pharmacol 91:275-286, 1987.
28. 28. MacLeod KM, McNeill JH: The influence of chronic experimental diabetes on contractile responses of rat isolated blood vessels. Can J Physiol Pharmacol 63:52-57, 1985.
29. 29. Özçelikay AT, Pekiner C, Ari N, Öztürk Y, Özüari A, Altan VM: The effect of vanadyl treatment on vascular responsiveness of streptozotocin-diabetic rats. Diabetologia 37:572-578, 1994.
30. 30. White RE, Carrier GO. Vascular contraction induced by activation of membrane calcium ion channels is enhanced in streptozotocin diabetes. J Pharmacol Exp Ther 253:1057-1062, 1990.
31. +-depolarized duodenum from alloxan-diabetic rats. Pharmacol Res 19:597-608, 1987.
32. 32. Aihara K, Sakai Y: Hyperreactivity of contractile response in gastric fundus smooth muscle from rats with diabetes induced by streptozotocin. Arch Int Pharmacodyn Ther 302:220-231, 1989.
33. 33. Fales FW, Russell JA, Fain JN: Some applications and limitations of the enzymatic, reducing (Somogyi) and anthrone methods for estimating sugars. Clin Chem 7:389-395, 1961.
34. 34. Malone JI, Root AW: Plasma free insulin concentrations: Keystone to effective management of diabetes mellitus in children. J Pediatr 99:862-867, 1981.
35. 35. Ferrari M, Carpenedo F: On the mechanism of action of some myolytic agents on depolarized guinea-pig taenia coli. Arch Int Pharmacodyn Ther 174:223-232, 1968.
36. +-depolarized rat duodenum. J Pharm Pharmacol 42: 874-877, 1990.
37. x values in analysis of pharmacodynamics. Arch Int Pharmacodyn Ther 110:275-299, 1957.
38. 38. Finney DJ (ed): Statistical Methods in Biological Assay. London, Griffin, 1978.
39. 39. Spedding M: Calcium antagonist subgroups. Trends Pharmacol Sci 6:109-114, 1985.
40. 40. Triggle DJ: Calcium, the control of smooth muscle and bronchial hyperreactivity. Allergy 38: 1-9, 1983.
41. 41. Öztürk Y, Aydin S, Altan VM, Yildizoǧlu-Ari N, Özçelikay AT: Effect of short and long term streptozotocin diabetes on smooth muscle calmodulin levels in the rat. Cell Calcium 16:81-86, 1994.